High hepatocyte growth factor levels in faeces during acute infectious gastroenteritis

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 11-12, 2003, Pages 858-862

  Nayeri, Fariba ^a   Almer, Sven ^a   Brudin, Lars ^b   Nilsson, Ingela ^b   Åkerlind, Britt ^a   Forsberg, Pia ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGENIC AGENT; SCATTER FACTOR;

ACUTE DIARRHEA; ACUTE GASTROENTERITIS; ADOLESCENT; ADULT; AGED; AMOEBA; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FECES LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PATIENT REFERRAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TISSUE REGENERATION; VACCINATION; VIRUS INFECTION; VOLUNTEER; WESTERN BLOTTING;

ACUTE DISEASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GASTROENTERITIS; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0346968471     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310016484     Document Type: Article

References (25)

1. Richard YU. Antibiotics in infectious gastroenteritis or diarrhoea. In: Armstrong and Cohen, eds. Infectious Diseases. First edition. London: Harcourt Publishers Ltd, 1999. p. 2.41.7.
2. Berkow R. Gastrointestinal disorders, diarrhoea and constipation, In: The Merck Manual, Sixteenth edition, Merck & Co., Inc. Rathway, N.J., 1992. p. 806-8.
3. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993; 268: 21212-7.
4. Sakaguchi H, Seki S, Tsubouchi H, Daikuhara Y, Niitani Y, Kobayashi K. Ultrastructural location of human hepatocyte growth factor in human liver. Hepatology 1994; 19: 1157-63.
5. Noji S, Tashiro K, Koyama E, Nohno E, Ohyama K, Taniguchi S, Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990; 173: 42-7.
6. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure and implications for a central role in liver regeneration. J Gastroenterology Hepatology 1991; 6: 509-19.
7. Arakaki N, Kawakami S, Nakamura O, Ohnishi T, Miyazaki H, Ishii T, Tsubouchi H, Daikuhara Y. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology 1995; 221: 1728-34.
8. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 1993; 268: 10024-8.
9. Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T, Kitamura N. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem 1992; 276: 20114-9.
10. Nishizaki T, Takenaka K, Yoshizumi T, Yanaga K, Soejima Y, Shirabe K, Sugimachi K. Alteration in levels of human hepatocyte growth factor following hepatectomy. J Am Coll Surg 1995; 181: 6-10.
11. Yanagita K, Nagaike H, Ishibashi Y, Niho K, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 1992; 182: 802-9.
12. Kono S, Nagaike M, Matsumoto K, Nakamura T. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem Biophys Res Commun 1992; 186: 991-8.
13. Nayeri F, Nilsson I, Brudin L, Fryden A, Söderström C. High serum hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases. Scand J Infect Dis 2002; 34: 127-30.
14. Nayeri F, Nilsson I, Hagberg L, Brudin L, Roberg M, Söderström C, Forsberg P. Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between acute bacterial and nonbacterial meningitis. J Infect Dis 2000; 181: 2092-4.
15. Nayeri F, Millinger E, Nilsson I, Zetterström O, Brudin L, Forsberg P. Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med 2002; 96: 115-9.
16. Nayeri F, Brudin L, Nilsson I, Forsberg P. Sample handling and stability of hepatocyte growth factor in serum during infection. Cytokine 2002; 19: 201-5.
17. Jones MK, Tomikawa M, Mohajer B, Tarnawski AS. Gastro-intestinal mucosal regeneration: role of growth factors. Front Biosci 1999; 4: D303-9. Review.
18. Rao RK, Koldovsky O, Grimes J, Williams C, Davis TP. Regional differences in gastrointestinal processing and absorption of epidermal growth factor in suckling rats. Am J Physiol 1991; 261: G790-8.
19. Coffey RJ, Ganarosa LM, Damstrup L, Dempsey PG. Basic actions of transforming growth factor-alpha and related peptides. Eur J Gastroenterol and Hepatol 1995; 7: 923-7.
20. Podolsky DK. Peptide growth factors in gastrointestinal tract. In: Physiology of the gastrointestinal tract. Third edition. Eds: Johnson L.R. New York: Raven Press; 1994. p. 129-167.
21. Nishimura S, Takahashi M, Ota S, Hirano M, Hiraishi H. Hepatocyte growth factor accelerates restitution of intestinal epithelial cells. J Gastroenterol 1998; 33: 172-8.
22. Kitamura S, Kondo S, Shinomura Y, Isozaki K, Kanayama S, Higashimoto S, et al. Expression of hepatocyte growth factor and c-met in ulcerative colitis. Inflamm Res 2000; 49: 320-4.
23. Nusrat A, Parkos C, Bacarra A, Godowski P, Delp-Archer C, Rosen E, Madara J. Hepatocyte growth factor/Scatter factor on epithelia. J Clin Invest 1994; 93: 2056-65.
24. Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med 1999; 17(6): 1019-25.
25. Matsuno M, Shiota G, Umeki K, Kawasaki H, Kojo H, Miura K. Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease. Res Commun Mol Pathol Pharmacol 1997; 97(1): 25-37.